NOVN:SWX
Novartis AG
CHF 124.20
arrow_downward
-0.40%(-0.50) 1D
Oct 19, 5:31:13 PM GMT+2 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOVN...
Open
CHF 124.32
High
CHF 125.06
Low
CHF 123.64
Mkt. cap
251.87B
Avg. vol.
3.49M
Volume
2.84M
Dividend
2.98%
Quarterly dividend
CHF 0.93
Ex-dividend date
Mar 10, 2026
P/E ratio
22.77
52-wk high
CHF 132.68
52-wk low
CHF 97.05
EPS
CHF 5.45
Shares outstanding
2.03B
No. of employees
75K
Open
CHF 124.32
High
CHF 125.06
Low
CHF 123.64
Mkt. cap
251.87B
Avg. vol.
3.49M
Volume
2.84M
Dividend
2.98%
Quarterly dividend
CHF 0.93
Ex-dividend date
Mar 10, 2026
P/E ratio
22.77
52-wk high
CHF 132.68
52-wk low
CHF 97.05
EPS
CHF 5.45
Shares outstanding
2.03B
No. of employees
75K
News stories
From web sources and news partners
marketscreener.com
·
1 hour ago
Switzerland's Blue-chip Index Kicks Off Week Downbeat; Novartis Shares Decline
Yahoo Finance
·
4 hours ago
Novartis Has Five Fast-Growing Drugs, but Is Its Valuation Asking Too Much?
ad-hoc-news.de
·
4 hours ago
Novartis stock: UBS keeps CHF 116.00 target for Novartis stock
ad-hoc-news.de
·
9 hours ago
Novartis ends Fabhalta trial while Novartis stock trades at EUR 134.82
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3K
FoundedMar 7, 1996
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websitenovartis.com